These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 2017158

  • 1. DuP 753 can antagonize the effects of angiotensin II in rat liver.
    Bauer PH, Chiu AT, Garrison JC.
    Mol Pharmacol; 1991 Apr; 39(4):579-85. PubMed ID: 2017158
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
    Crawford KW, Frey EA, Cote TE.
    Mol Pharmacol; 1992 Jan; 41(1):154-62. PubMed ID: 1310139
    [Abstract] [Full Text] [Related]

  • 3. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
    Cogan MG, Liu FY, Wong PC, Timmermans PB.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
    [Abstract] [Full Text] [Related]

  • 4. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [Abstract] [Full Text] [Related]

  • 5. Subclasses of angiotensin II binding sites and their functional significance.
    Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE.
    Mol Pharmacol; 1990 Sep; 38(3):370-7. PubMed ID: 2402226
    [Abstract] [Full Text] [Related]

  • 6. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT, McCall DE, Price WA, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [Abstract] [Full Text] [Related]

  • 7. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
    Nouet S, Dodey P, Renaut P, Marie J, Pruneau D, Larguier R, Lombard C, Bonnafous JC.
    Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
    [Abstract] [Full Text] [Related]

  • 8. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC, Timmermans PB.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):49-57. PubMed ID: 2072311
    [Abstract] [Full Text] [Related]

  • 9. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
    Chang RS, Lotti VJ.
    Mol Pharmacol; 1990 Mar 01; 37(3):347-51. PubMed ID: 2314387
    [Abstract] [Full Text] [Related]

  • 10. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
    Cobb CS, Brown JA.
    Gen Comp Endocrinol; 1993 Oct 01; 92(1):123-31. PubMed ID: 8262354
    [Abstract] [Full Text] [Related]

  • 11. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
    Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E.
    Cardiologia; 1993 Jul 01; 38(7):471-6. PubMed ID: 8221742
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR, Lo MW, Christ DD, Chiou R, Furtek CI, Amit O, Carides A, Biollaz J, Piguet V, Nussberger J, Brunner HR.
    Clin Pharmacol Ther; 1997 Jan 01; 61(1):59-69. PubMed ID: 9024174
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb 01; 252(2):726-32. PubMed ID: 2179532
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells.
    Moreau C, Rasolonjanahary R, Audinot V, Kordon C, Enjalbert A.
    Mol Cell Neurosci; 1994 Dec 01; 5(6):597-603. PubMed ID: 7704434
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin II stimulates phosphoinositide turnover and phosphorylase through AII-1 receptors in isolated rat hepatocytes.
    García-Sáinz JA, Macías-Silva M.
    Biochem Biophys Res Commun; 1990 Oct 30; 172(2):780-5. PubMed ID: 2173579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.